Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Patriarca

Showing results (11-20 of 156) with videos related to

Pageof 16
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 27, 2026
Adherence to oral immunosuppressors using therapeutic drug monitoring: A retrospective studyXhesika Ikonomi, Chiara Visintini, Margherita Venturini, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 26, 2021
Emerging therapy in light-chain and acquired transthyretin-related amyloidosis: an Italian single-centre experience in heart transplantationConcetta Di Nora, Sandro Sponga, Veronica Ferrara, et al.
Leukemia & Lymphoma|January 24, 2004
Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseasesFrancesco Zaja, Nicola Vianelli, Alessandra Sperotto, et al.
Haematologica|February 8, 2006
Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcomeCristina Skert, Francesca Patriarca, Alessandra Sperotto, et al.
European Journal of Haematology|May 31, 2008
Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up resultsMarta Medeot, Francesco Zaja, Nicola Vianelli, et al.
Advances in Clinical Pathology : the Official Journal of Adriatic Society of Pathology|September 17, 2009
Autologous stem cell transplantation for Hodgkin's lymphoma: results and prognostic factors in 51 high-risk patientsAlessandra Sperotto, Daniela Damiani, Francesco Zaja, et al.
Transplantation Direct|January 23, 2026
Intensification of Treosulfan-Fludarabine Conditioning With Thiotepa Exhibited Effectiveness and Tolerability in Older or Comorbid Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant With Active Myeloid Neoplasm: A Real-world StudyLuca Tosoni, Gabriele Facchin, Rosa Plos, et al.
Haematologica|April 21, 2009
Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantationLucia Farina, Cristiana Carniti, Anna Dodero, et al.
Transplantation and Cellular Therapy|April 4, 2021
Cytomegalovirus Prophylaxis versus Pre-emptive Strategy: Different CD4<sup>+</sup> and CD8<sup>+</sup> T Cell Reconstitution after Allogeneic Hematopoietic Stem Cell TransplantationAlessandra Sperotto, Anna Candoni, Michele Gottardi, et al.
Frontiers in Immunology|September 2, 2025
Post-transplant cyclophosphamide in haploidentical stem cell transplantation: evaluating the impact of transplant conditioning intensityUmberto Pizzano, Simona Piemontese, Gabriele Facchin, et al.
Pageof 16

Showing results (11-20 of 156) with videos related to

Sort By:
Pageof 16
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 27, 2026
Adherence to oral immunosuppressors using therapeutic drug monitoring: A retrospective studyXhesika Ikonomi, Chiara Visintini, Margherita Venturini, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 26, 2021
Emerging therapy in light-chain and acquired transthyretin-related amyloidosis: an Italian single-centre experience in heart transplantationConcetta Di Nora, Sandro Sponga, Veronica Ferrara, et al.
Leukemia & Lymphoma|January 24, 2004
Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseasesFrancesco Zaja, Nicola Vianelli, Alessandra Sperotto, et al.
Haematologica|February 8, 2006
Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcomeCristina Skert, Francesca Patriarca, Alessandra Sperotto, et al.
European Journal of Haematology|May 31, 2008
Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up resultsMarta Medeot, Francesco Zaja, Nicola Vianelli, et al.
Advances in Clinical Pathology : the Official Journal of Adriatic Society of Pathology|September 17, 2009
Autologous stem cell transplantation for Hodgkin's lymphoma: results and prognostic factors in 51 high-risk patientsAlessandra Sperotto, Daniela Damiani, Francesco Zaja, et al.
Transplantation Direct|January 23, 2026
Intensification of Treosulfan-Fludarabine Conditioning With Thiotepa Exhibited Effectiveness and Tolerability in Older or Comorbid Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant With Active Myeloid Neoplasm: A Real-world StudyLuca Tosoni, Gabriele Facchin, Rosa Plos, et al.
Haematologica|April 21, 2009
Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantationLucia Farina, Cristiana Carniti, Anna Dodero, et al.
Transplantation and Cellular Therapy|April 4, 2021
Cytomegalovirus Prophylaxis versus Pre-emptive Strategy: Different CD4<sup>+</sup> and CD8<sup>+</sup> T Cell Reconstitution after Allogeneic Hematopoietic Stem Cell TransplantationAlessandra Sperotto, Anna Candoni, Michele Gottardi, et al.
Frontiers in Immunology|September 2, 2025
Post-transplant cyclophosphamide in haploidentical stem cell transplantation: evaluating the impact of transplant conditioning intensityUmberto Pizzano, Simona Piemontese, Gabriele Facchin, et al.
Pageof 16